SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Paimon SpaceX SPV Token (SPCX) offers investors exclusive access to SpaceX's growth potential through a British Virgin Islands Special Purpose Vehicle structure. Each token represents fractional ownership in the underlying SPV that invests in venture capital funds with SpaceX exposure. SPCX provides a unique opportunity to participate in the space industry's leading innovator. The token structure enables global qualified investors to access this premium late-stage venture equity that would typically be unavailable to most. SPCX is deployed on BNB Chain with plans for multi-chain expansion.

Paimon SpaceX SPV Token

The ticker SPCX is surging amid widespread speculation and unconfirmed reports regarding a potential SpaceX IPO on the Nasdaq, leading to significant retail enthusiasm and debate over the legitimacy of the token. Community members are actively discussing the possibility of a major public listing while navigating concerns over potential scams and the impact this event could have on other aerospace sector proxies.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAIL shares have experienced a significant sell-off after the company's multi-cancer early detection test failed to meet its primary clinical endpoint in a large-scale NHS study. While the community is debating whether this represents a total failure or an overreaction given the company's solid cash position and potential for early-stage cancer detection, investors remain highly cautious about the long-term regulatory path and the company's significant cash burn.

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin ($BNKR) is attracting significant community attention as a foundational infrastructure for autonomous AI agents within the Base ecosystem. Investors are actively debating its potential for utility-driven growth, often highlighting the ongoing development of its bot capabilities and strategic accumulation phase.

ConocoPhillips is an exploration and production company, which engages in the exploration, production, transport, and marketing of crude oil, bitumen, and natural gas. It operates through the following geographical segments: Alaska, Lower 48, Canada, Europe, Middle East, and North Africa, Asia Pacific, and Other International. The Alaska segment explores for, produces, transports and markets crude oil, natural gas and NGLs. The Lower 48 segment consists of operations located in the 48 contiguous U.S. states and the Gulf of Mexico. The Canada segment refers to oil sands development in the Athabasca Region of northeastern Alberta and a liquids-rich unconventional play in western Canada. The Europe, Middle East, and North Africa segment includes operations in the Norwegian sector of the North Sea, the Norwegian Sea, Qatar, Libya, Equatorial Guinea and commercial and terminalling operations in the U.K. The Asia Pacific segment focuses on explorations and product operations in China, Indonesia, Malaysia, and Australia. The Other International segment handles exploration activities in Columbia and Argentina. The company was founded by Isaac Elder Blake on November 25, 1875 and is headquartered in Houston, TX.

Conoco Phillips

ConocoPhillips is currently trending as investors weigh potential production shifts, geopolitical tensions, and recent reports of corporate workforce reductions. The community is actively debating the stock's long-term value, with many focusing on its dividend reliability and the operational impact of upcoming strategic shifts in the global energy market.

Evolution Metals & Technologies Corp. engages in developing a global supply chain for critical minerals and materials. It focuses on automotive, renewable energy, and military and defense sectors. The company is headquartered in West Palm Beach, FL.

Evolution Metals & Technologies Corp.

Evolution Metals & Technologies Corp. Common Stock

Evolution Metals & Technologies Corp. (EMAT) is gaining significant community attention as investors speculate on its role in domestic critical mineral supply chain independence and its transition toward a vertically integrated industrial platform. While some participants are closely monitoring the stock's recent volatility and low-float dynamics for potential momentum, others are debating the long-term execution of its expansion plans and the impact of its new equipment and funding agreements.

Investment Managers Series Trust II - Tradr 1.5X Short NVDA Daily ETF

Tradr 1.5X Short NVDA Daily ETF

Investors are actively debating the potential for an NVIDIA price correction, with many utilizing $NVDS as a leveraged hedging tool to capitalize on volatility or bet against current valuations. The community remains divided, weighing the risks of hyper-growth against technical indicators that suggest the stock may be overextended.

Protara Therapeutics, Inc. is a clinical-stage company engaged in developing treatments for rare and specialty diseases with significant unmet needs. Its current development programs focus on the treatment of rare diseases in structural and connective tissues and rare hepatology, gastrointestinal, and metabolic disorders. The company was founded by Jesse Shefferman and Jacqueline Zummo in March 2006 and is headquartered in New York, NY.

Protara Therapeutics Inc

Protara Therapeutics is currently attracting significant community attention following positive interim data from its ADVANCED-2 trial, which reported a 100% complete response rate in certain BCG-unresponsive bladder cancer cohorts. Investors are actively discussing the stock's potential for accelerated regulatory pathways, the strategic advantage of its orphan drug status, and the long-term cash runway fueling development for its lead TARA-002 compound.

Pan American Silver Corp. engages in the operation, development, and exploration of silver and gold producing properties and assets. It operates through the Silver and Gold segments. The Silver segment includes La Colorada, Huaron, Morococha, San Vicente, and Manantial Espejo mines. The Gold segment refers to the Dolores, Shahuindo, La Arena, Timmins West, and Bell Creek mines. The company was founded by Ross J. Beaty and John H. Wright on March 7, 1979 and is headquartered in Vancouver, Canada.

Pan American Silver Corp

Pan American Silver (PAAS) is currently trending as investors focus on the company's strong production growth and its leverage to the ongoing silver price surge, with active community discussions highlighting the widening gap between paper silver prices and physical market shortages. Analysts are bullish on the company's improved outlook, fueled by recent project updates and record cash flow, while the community actively debates whether the stock is undervalued relative to its industrial-critical metal assets and the long-term potential of the precious metals super-cycle.

Orla Mining Ltd. is a capital pool company, which engages in the business of acquisition, exploration, development, and operation of mineral properties. Its material gold projects include Camino Rojo, South Railroad, and Cerro Quema. The company was founded on May 31, 2007 and is headquartered in Vancouver, Canada.

Orla Mining Ltd

Orla Mining is seeing increased investor focus due to its active role in gold sector M&A and ongoing production milestones, despite community frustration over recent equity dilution concerns. The community remains divided between those accumulating shares as a long-term hedge and traders skeptical of its short-term price performance and potential deal structure.

Lantronix, Inc. engages in the provision of software as a service (SaaS), engineering services, and hardware for Edge Computing, the Internet of Things (IoT), and Remote Environment Management (REM). Its services include Embedded IoT Solutions, IoT Systems Solutions, and Software and Engineering Services. The company was founded by Bernhard Bruscha in June 1989 and is headquartered in Irvine, CA.

Lantronix Inc

Lantronix is trending due to heightened investor interest following its recent earnings report and strategic expansion into the AI-driven drone market. Community discussions are centered on the company's partnerships with major tech players, its role in defense-related autonomous systems, and optimism surrounding its long-term growth potential in edge computing.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

LivaNova (LIVN) Upgraded to Buy: Here's What You Should Know

LivaNova (LIVN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

LivaNova Q1 Earnings Call Highlights

LivaNova (NASDAQ:LIVN) reported first-quarter 2026 results that management said reflected "durable performance" across its cardiopulmonary and epilepsy businesses, while also highlighting recent regulatory and clinical milestones that it believes position the company for entry into the obstructive s...

LivaNova (LIVN) Q2 2025 Earnings Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

LivaNova (LIVN) Q1 Earnings and Revenues Surpass Estimates

LivaNova (LIVN) delivered earnings and revenue surprises of +15.29% and +3.60%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

LivaNova (NASDAQ:LIVN) Issues FY 2026 Earnings Guidance

LivaNova (NASDAQ:LIVN) updated its FY 2026 earnings guidance. The company provided EPS guidance of 4.200-4.300 for the period, compared to the consensus estimate of 4.100. The company also issued...

LivaNova Reports First-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the first quarter ended March 31, 2026 and raised full-year 2026 guidance. Financial Summary and...

LivaNova (LIVN) Projected to Post Earnings on Wednesday

LivaNova (NASDAQ:LIVN) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 6. (View Earnings Report at...

Peregrine Capital Management LLC Invests $3.83 Million in LivaNova PLC $LIVN

Peregrine Capital Management LLC acquired a new position in LivaNova PLC (NASDAQ:LIVN - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange...

LivaNova (NASDAQ:LIVN) Shares Cross Below 50 Day Moving Average   - Here's Why

LivaNova (NASDAQ:LIVN) Stock Passes Below 50-Day Moving Average - Here's What Happened...

Annals of Internal Medicine Publishes 12-Month Results from LivaNovas OSPREY Clinical Study for Obstructive Sleep Apnea

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that the journal Annals of Internal Medicine has published an article chronicling the full 12-month data set...

LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. It operates through the following segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support (ACS). The Cardiopulmonary segment is involved in the design, development, manufacture, marketing and selling of cardiopulmonary products. The Neuromodulation segment is associated in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating DRE and DTD. The ACS segment deals with the design, development, manufacture, marketing and selling of temporary life support products. The company was founded in 1987 and is headquartered in London, the United Kingdom.

Current Price	$70.00
Prev Close	$71.67
Open	$71.12
Dividend Yield	0.00%
50-Day Moving Average	$64.08
Beta	0.95
Avg. Volume	726,370.13
PE Ratio	36.13

52-Week High	$73.30
52-Week Low	$41.02
Market Capitalization	$3.85B
EPS (Annual)	-$4.45
Price to Book	3.17
Revenue Per Employee	$420,622.12

LIVN
LivaNova PLC

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LIVN News

LIVNLivaNova PLC